Search
for
Sort by
Research 30 of 305
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Cutaneous adverse effects of targeted therapies
- Nilotinib-Induced Keratosis Pilaris
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Unusual Presentation of Childhood Leukemia With Vaginal Bleeding: A Case Report
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- The PDGF/PDGFR pathway as a drug target
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Cutaneous drug reactions
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- The JAK/STAT signaling pathway: from bench to clinic
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- miR-133a-3p and miR-145-5p co-promote goat hair follicle stem cell differentiation by regulating NANOG and SOX9 expression
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Protein Kinase C as a Therapeutic Target
- Aberrant Activation of the Hedgehog Signaling Pathway in Malignant Hematological Neoplasms